Sanofi COPD Study WellNow Clinical Research


We are enrolling patients in our clinical trial for a new COPD medication. Patients in this trial should have a diagnosis of moderate COPD (Chronic obstructive pulmonary disease) for at least 12 months before study entry. Participants will attend 19 study visits over the course of 64 weeks.

Qualified Participants are: 

  • Patients diagnosed of moderate COPD for at least 12 months before study


5965 Transit Road, Suite 200

Buffalo, New York 14051

(716) 428-5228

COPD Study - Buffalo

WellNow Urgent Care & Research partners with multinational pharmaceuticals, biotechnology companies, medical device manufacturers & CROs to help drive improvements to health and well-being. In our 15 years of research, WellNow has had over 17,000 visits to our network of clinical research sites.
Facebook for wellnow research
Youtube for WN research
Twitter for WN Research